Profund Advisors LLC Moderna, Inc. Transaction History

Profund Advisors LLC

$2.65 Billion
Q2 2024

A detailed history of Profund Advisors LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 56,218 shares of MRNA stock, worth $3.7 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

56,218

Previous 46,499 20.9%

Holding current value

$3.7 Million

Previous $4.95 Million 34.74%

% of portfolio

0.25%

Previous 0.2%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$101.21 - $166.61 $983,659 - $1.62 Million	9,719 Added 20.9%	56,218 $6.68 Million
Q1 2024 May 08, 2024	SELL	$85.37 - $115.44 $549,270 - $742,740	-6,434 Reduced 12.15%	46,499 $4.95 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $705,456 - $1.06 Million	10,149 Added 23.72%	52,933 $5.26 Million
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $838,477 - $1.1 Million	8,697 Added 25.51%	42,784 $4.42 Million
Q2 2023 Aug 10, 2023	BUY	$118.5 - $160.53 $471,511 - $638,748	3,979 Added 13.22%	34,087 $4.14 Million
Q1 2023 May 11, 2023	SELL	$135.66 - $197.02 $3.44 Million - $5 Million	-25,353 Reduced 45.71%	30,108 $4.62 Million
Q4 2022 Feb 02, 2023	SELL	$118.38 - $210.04 $154,130 - $273,472	-1,302 Reduced 2.29%	55,461 $9.96 Million
Q3 2022 Nov 04, 2022	SELL	$118.07 - $194.18 $521,869 - $858,275	-4,420 Reduced 7.22%	56,763 $6.71 Million
Q2 2022 Aug 01, 2022	SELL	$117.13 - $176.59 $1.17 Million - $1.76 Million	-9,974 Reduced 14.02%	61,183 $8.74 Million
Q1 2022 May 10, 2022	SELL	$126.46 - $235.05 $1.9 Million - $3.53 Million	-15,014 Reduced 17.42%	71,157 $12.3 Million
Q4 2021 Feb 08, 2022	SELL	$225.82 - $368.51 $2.07 Million - $3.38 Million	-9,175 Reduced 9.62%	86,171 $21.9 Million
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $2.4 Million - $5.24 Million	10,816 Added 12.8%	95,346 $36.7 Million
Q2 2021 Aug 12, 2021	SELL	$129.91 - $234.98 $297,623 - $538,339	-2,291 Reduced 2.64%	84,530 $19.9 Million
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $153,288 - $261,115	1,404 Added 1.64%	86,821 $11.4 Million
Q4 2020 Feb 09, 2021	BUY	$65.74 - $169.86 $450,384 - $1.16 Million	6,851 Added 8.72%	85,417 $8.92 Million
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $710,658 - $1.24 Million	13,078 Added 19.97%	78,566 $5.56 Million
Q2 2020 Aug 03, 2020	BUY	$29.67 - $80.0 $791,417 - $2.13 Million	26,674 Added 68.72%	65,488 $4.21 Million
Q1 2020 May 15, 2020	SELL	$17.78 - $31.58 $251,907 - $447,425	-14,168 Reduced 26.74%	38,814 $1.16 Million
Q4 2019 Feb 18, 2020	BUY	$13.93 - $21.28 $81,755 - $124,892	5,869 Added 12.46%	52,982 $1.04 Million
Q3 2019 Nov 12, 2019	BUY	$12.26 - $18.07 $577,605 - $851,331	47,113 New	47,113 $750,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Moderna, Inc. Transaction History